iTeos Therapeutics, Inc.

CAMBRIDGE, MA How do I update this listing?

Iteos Therapeutics is based out of Cambridge. iTeos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops immuno-oncology therapeutics for treatment of patients. iTeos Therapeutics serves customers in the United States and Belgium. The firm last filed a Form D notice of exempt offering of securities on 2020-04-09. The notice included securities offered of Equity

Create Alert

Contact Info

iteos therapeutics, inc.
139 MAIN STREET
CAMBRIDGE MA    02142

Business Phone: 857-204-4583
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-04-09 D OTHER TECHNOLOGY Equity 125,358,806 125,358,806 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANSBERT GADICKE subscription required
    DIRECTOR
CHRIS BUYSE subscription required
    DIRECTOR
DAVID HALLAL subscription required
    DIRECTOR
DETLEV BINISZKIEWICZ subscription required
    DIRECTOR
JONATHAN SKIPPER subscription required
    DIRECTOR
MICHEL DETHEUX subscription required
    EXECUTIVE OFFICER DIRECTOR
PRIYANKA BELAWAT subscription required
    DIRECTOR
TIM VAN HAUWERMEIREN subscription required
    DIRECTOR

Elevate your investments